FUJIFILM VisualSonics won FDA clearance to introduce the world’s first clinical ultra high frequency ultrasound system. The compatible transducers operate at frequencies up to 70 MHz, providing imaging details down to 30 micrometers. Typical ultrasounds go up to about 15 MHz, but while imaging resolution is significantly improved by the Vevo MD, the depth of penetration is only a few centimeters.

That’s why the system is expected to be used for imaging nerves, vasculature just below the skin, the skin itself, and potentially during surgeries to spot objects of interest and to avoid unnecessary damage. It may also find uses in neonatology and pediatrics where the small penetration depth is not as much of an issue, while smaller anatomy requires a higher imaging resolution.

The Vevo MD received European regulatory approval back in January of this year.

Here are a bunch of potential applications of the new ultrasound technology, according to the Vevo MD product page:


  • arteries and veins in pediatric and neonatal patients
  • measurement of Intima-Media Thickness (IMT) for research and assessment of cardiovascular health
  • assessment of vein wall morphology for cannulation readiness in AV fistula patients
  • assessment of peripheral vessels in diabetes and other circulatory conditions
  • visualization of flow patterns in in atherosclerotic or abnormal vessels

Small parts:

  • Nerves
  • Hand Transplants
  • Thyroid and glands
  • Lymph Nodes
  • Male reproductive organs


  • Detection and monitoring of Inflammatory Arthritis through better definition of synovium and cartilage of the finger and wrist joints.
  • Differentiation of normal vs. inflamed tendons (Tenosynovitis)
  • Visualize the “Anatomical Snuffbox”
  • Carpal and Tarsal Tunnel Syndrome
  • Assessment of Medial Meniscus
  • Assessment of Pediatric Hip Dysplasia


  • Skin layers
  • Melanoma
  • Lipomas
  • Hair follicles (hair loss)
  • Foreign Body Identification
  • Lumps and Bumps




Source: FUJIFILM VisualSonics…


Submit a comment

Your email address will not be published. Required fields are marked *

Leave comment

There are 0 comments